Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 30, 2019 - Issue 6
Submit an article Journal homepage
114
Views
5
CrossRef citations to date
0
Altmetric
Psoriasis

Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy

Mohammed Abu El-HamdDepartment of Dermatology, Venereology and Andrology, Sohag University, Sohag, Egypt; Correspondence[email protected]
,
Moustafa Adam El TaiebDepartment of Dermatology, Venereology and Andrology, Aswan University, Aswan, Egypt;
,
Abdallah Abdallah MahmoudDepartment of Medical Biochemistry, Aswan University, Aswan, Egypt
&
Ola Mahmoud SamyDepartment of Dermatology, Venereology and Andrology, Aswan University, Aswan, Egypt;
Pages 545-548 | Received 05 Oct 2018, Accepted 27 Oct 2018, Published online: 28 Nov 2018

References

  • Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol. 2001;15:16–17.
  • Gelfand J, Weinstein R, Porter S. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141:1537–1541.
  • Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:450–456.
  • Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866–873.
  • Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–255.
  • Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352:1899–1912.
  • Feldman S, Krueger G. Assessment: domains and instruments. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64:65–73.
  • Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Phys. 2017;63:278–285.
  • Yuehua Y, Khalaf AT, Xiaoxang Z. Narrow-band ultraviolet and convention UVB phototherapy in psoriasis: a randomized controlled trial. Am J Appl Sci. 2008;5:905.
  • Bussink AP, Speijer D, Aerts JM, et al. Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics. 2007;177:959–997.
  • Lee CG, Da Silva CA, la Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479–501.
  • Imai Y, Aochi S, Iwatsuki K, et al. YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis. J Dermatol. 2013;40:294–296.
  • Salomon J, Matusiak L, Nowicka-Suszko D, et al. Chitinase-3-like protein 1 (YKL-40) is a new biomarker of inflammation in psoriasis. Mediators Inflamm. 2017;2017:9538451.
  • Baran A, Myśliwiec H, Szterling-Jaworowska M, et al. Serum YKL-40 as a potential biomarker of inflammation in psoriasis. J Dermatolog Treat. 2018;29:19–23.
  • Ahmed SF, Attia EA, Saad AA, et al. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings. J Eur Acad Dermatol Venereol. 2015;29:682–688.
  • Imai Y, Tsuda T, Aochi S, et al. YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis. J Dermatol Sci. 2011;64:75–77.
  • Ataseven A, Kesli R. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40. G Ital Dermatol Venereol. 2016;151:244–250.
  • Jensen P, Wiell C, Milting K, et al. Plasma YKL-40: a potential biomarker for psoriatic arthritis? J Eur Acad Dermatol Venereol. 2013;27:815–819.
  • Al Robaee AA, Alzolibani AA. Narrowband ultraviolet B phototherapy improves the quality of life in patients with psoriasis. Saudi Med J. 2011;32:603–606.
  • Archier E, Devaux S, Castela E, et al. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:11–21.
  • Almutawa F, Alnomair N, Wang Y, et al. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 2013;14:87–109.
  • Erfan G, Guzel S, Alpsoy S, et al. Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis? Mol Cell Biochem. 2015;400:207–212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.